study_id,year,design,effect_type,effect_point,ci_low,ci_high,n_treat,n_ctrl,risk_of_bias,doi,journal_id,outcome,population,adverse_events,duration_weeks
SLP-MEL-ACUTE_01,2006,randomized controlled trial,SMD,-0.3120,-0.4564,-0.1676,56,53,some concerns,10.1234/slp-mel-acute-01,sleep_journal,sleep_onset,Adults with sleep onset concerns,Mild GI discomfort,7
SLP-MEL-ACUTE_02,2007,randomized controlled trial,SMD,-0.3360,-0.4869,-0.1852,60,56,mixed,10.1234/slp-mel-acute-02,sleep_journal,sleep_onset,Adults with sleep onset concerns,Transient headache,8
SLP-MEL-ACUTE_03,2008,randomized controlled trial,SMD,-0.4234,-0.5518,-0.2950,64,59,low,10.1234/slp-mel-acute-03,sleep_journal,sleep_onset,Adults with sleep onset concerns,None reported,9
